Cognition Therapeutics has a total of 160 patents globally, out of which 54 have been granted. Of these 160 patents, more than 56% patents are active. The United States of America is where Cognition Therapeutics has filed the maximum number of patents, followed by Australia and Europe. Parallelly, The United States of America seems to be the main focused R&D center and also USA is the origin country of Cognition Therapeutics. Cognition Therapeutics was founded in the year 2007. Cognition Therapeutics operates as a biopharmaceutical company and discovers and develops small molecule therapeutics targeting toxic proteins that cause cognitive decline associated with alzheimer’s disease and other degenerative diseases of the human brain. Cognition Therapeutics serves customers worldwide. Do read about some of the most popular patents of Cognition Therapeutics which have been covered by us in this article and also you can find Cognition Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Cognition Therapeutics patent portfolio.
How many patents does the Founder and CEO of Cognition Therapeutics have?
The Founder Gilbert M. Rishton has 148 and Susan Catalano have 153 patents and the CEO Lisa Ricciardi have 10 patents.
How many patents does Cognition Therapeutics have?
Cognition Therapeutics has a total of 160 patents globally. These patents belong to 21 unique patent families. Out of 160 patents, 90 patents are active.
How Many Patents did Cognition Therapeutics File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Cognition Therapeutics Applications Filed | Cognition Therapeutics Patents Granted |
| 2023 | 3 | 4 |
| 2022 | 2 | 11 |
| 2021 | 16 | 1 |
| 2020 | 2 | 2 |
| 2019 | 4 | 10 |
| 2018 | 16 | 1 |
| 2017 | 3 | 6 |
| 2016 | 7 | 7 |
| 2015 | 28 | 9 |
| 2014 | 4 | 2 |
| 2013 | 1 | – |
| 2012 | 36 | – |
| 2011 | 4 | – |
How many Cognition Therapeutics patents are Alive/Dead?
Worldwide Patents 
How Many Patents did Cognition Therapeutics File in Different Countries?
Countries in which Cognition Therapeutics Filed Patents
| Country | Patents |
| United States Of America | 22 |
| Australia | 12 |
| Europe | 11 |
| China | 10 |
| Japan | 9 |
| Hong Kong (S.A.R.) | 9 |
| Israel | 8 |
| India | 7 |
| Russia | 7 |
| Brazil | 7 |
| Singapore | 5 |
| Germany | 5 |
| Austria | 5 |
| Canada | 5 |
| Spain | 4 |
| Korea (South) | 4 |
| New Zealand | 4 |
| Denmark | 4 |
| South Africa | 4 |
| Mexico | 3 |
| Italy | 1 |
Where are Research Centers of Cognition Therapeutics Patents Located?
10 Best Cognition Therapeutics Patents
WO2015116923A1 is the most popular patent in the Cognition Therapeutics portfolio. It has received 40 citations so far from companies like Janssen Sciences Ireland Uc, Novira Therapeutics and Polycore Therapeutics.
Below is the list of 10 most cited patents of Cognition Therapeutics:
| Publication Number | Citation Count |
| WO2015116923A1 | 40 |
| WO2010118055A1 | 36 |
| US20150160228A1 | 16 |
| WO2012106426A1 | 14 |
| US7723377B2 | 11 |
| US9499462B2 | 6 |
| US9192585B2 | 6 |
| US20140378460A1 | 6 |
| US20110111068A1 | 6 |
| US9796672B2 | 5 |
What Percentage of Cognition Therapeutics US Patent Applications were Granted?
Cognition Therapeutics (Excluding its subsidiaries) has filed 22 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 10 have been granted leading to a grant rate of 55.5%. Below are the key stats of Cognition Therapeutics patent prosecution at the USPTO. 
Which Law Firms Filed Most US Patents for Cognition Therapeutics?
| Law Firm | Total Applications | Success Rate |
| Dla Piper Llp | 13 | 100.00% |
| Troutman Pepper Hamilton Sanders Llp | 9 | 11.11% |
What are Cognition Therapeutics key innovation segments?
What Technologies are Covered by Cognition Therapeutics?
The chart below distributes patents filed by Cognition Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Cognition Therapeutics thinks it’s important to protect particular technology inventions.
R&D Focus: How has Cognition Therapeutics search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!